Predictive value of the combined use of NT-proBNP and CA125 biomarkers in a cohort of 138 patients with heart failure with reduced ejection fraction | Synapse
March 31, 2026
Predictive value of the combined use of NT-proBNP and CA125 biomarkers in a cohort of 138 patients with heart failure with reduced ejection fraction
Key Points
Key points are not available for this paper at this time.